Method for treatment of depression using synaptic pathway training
View Patent ↗Disclosed are methods of treating depression, mania, post-traumatic stress disorder (PTSD), and various other neurologic conditions using synaptic pathway training. Methods of synaptic pathway training include, generally, achieving a favorable treatment result by activating a synaptic pathway using a pharmacologic agent, such as treating refractory symptoms of depression with ketamine, following by potentiation of the favorable result by repeatedly stimulating the activated pathway. Stimulation of a synaptic pathway may be achieved by intrinsic means, such as performance of cognitive exercised, or extrinsic means, such as by delivery of a sensory stimulus to the patient, placing a potential voltage difference across the brain or a brain region, or by placing the brain or a brain region in a magnetic field.
1. A method of treating a neurologic condition by synaptic pathway training comprising the steps of:
activating a synaptic pathway with a pharmacologic agent in an amount in the range of from about 0.5 to about 1 mg/kg; and
stimulating the activated synaptic pathway.
2. The method of claim 1 , wherein the pharmacologic agent comprises an N-methyl-D-aspartate receptor antagonist.
3. The method of claim 1 , wherein the pharmacologic agent is a muscarinic receptor antagonist which comprises scopolamine.
4. The method of claim 1 , wherein the pharmacologic agent is a member selected from the group of pharmacologic agents consisting of ketamine, Namenda, dextromethorphan, amantadine, dextropropoxyphene, and ketobemidone.
5. The method of claim 1 , wherein the pharmacologic agent is a serotonin receptor antagonist which comprises psilocybin.
6. The method of claim 1 , wherein the pharmacologic agent is phencyclidine.
7. The method of claim 1 , wherein the pharmacologic agent is lysergic acid diethylamide.
8. The method of claim 1 , wherein the neurologic condition is depression.
9. The method of claim 1 , wherein the neurologic condition is bipolar disorder.
10. The method of claim 1 , wherein the neurologic condition is post-traumatic stress disorder.
11. The method of claim 1 , wherein stimulating the synaptic pathway comprises performance of a cognitive training exercise.
12. The method of claim 1 , wherein the stimulating step comprises exposure of a person to a sensory stimulus.
13. The method of claim 1 , wherein the stimulating step comprises applying a magnetic field to a region of a brain.
14. The method of claim 1 , wherein the stimulating step comprises applying a potential voltage difference to a region of a brain.
15. A method of enhancing treatment of a neurologic condition comprising the steps of:
treating the condition with a pharmacologic agent to alter a synaptic pathway; and
repeatedly stimulating the altered synaptic pathway with a neural stimulating means, wherein the pharmacological agent is not delivered during the stimulating.
16. The method of claim 15 , wherein the stimulating of the altered synaptic pathway comprises performance of a cognitive training exercise.
17. The method of claim 15 , wherein the stimulating of the altered synaptic pathway comprises providing an external source of stimulation.
18. The method of claim 17 , wherein the external source is a magnetic field, a potential voltage difference, or an auditory stimulus.
19. A method of treating a neurologic condition by synaptic pathway training comprising the steps of:
activating a synaptic pathway by administering at least one dose of ketamine, in an amount in the range of from about 0.5 mg/kg to about 1.0 mg/kg; and
stimulating the activated synaptic pathway by performing a cognitive training exercise for at least thirty (30) minutes daily.
20. The method of claim 19 , wherein the neurologic condition is depression, mania, or post-traumatic stress disorder.